Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 378 entries
Sorted by: Best Match Show Resources per page
Notes on Lithotrity, with an Account of the Results of the Operation in the Author's Practice.

Medico-chirurgical transactions

Brodie BC.
PMID: 20896041
Med Chir Trans. 1855;38:169-94. doi: 10.1177/095952875503800112.

No abstract available.

Cite
Brodie BC. Notes on Lithotrity, with an Account of the Results of the Operation in the Author's Practice. Med Chir Trans. 1855;38:169-94doi: 10.1177/095952875503800112.
Brodie, B. C. (1855). Notes on Lithotrity, with an Account of the Results of the Operation in the Author's Practice. Medico-chirurgical transactions, 38169-94. https://doi.org/10.1177/095952875503800112
Brodie, B C. "Notes on Lithotrity, with an Account of the Results of the Operation in the Author's Practice." Medico-chirurgical transactions vol. 38 (1855): 169-94. doi: https://doi.org/10.1177/095952875503800112
Brodie BC. Notes on Lithotrity, with an Account of the Results of the Operation in the Author's Practice. Med Chir Trans. 1855;38:169-94. doi: 10.1177/095952875503800112. PMID: 20896041; PMCID: PMC2104301.
Copy Download .nbib Format: NLM
The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study.

Journal of the Intensive Care Society

Wahab R, Yip NH, Chandra S, Nguyen M, Pavlovich KH, Benson T, Vilotijevic D, Rodier DM, Patel KR, Rychcik P, Perez-Mir E, Boyle SM, Berlin D, Needham DM, Brodie D.
PMID: 28979452
J Intensive Care Soc. 2016 Feb;17(1):2-11. doi: 10.1177/1751143715605118. Epub 2015 Sep 21.

INTRODUCTION: Survivors of critical illness face many potential long-term sequelae. Prior studies showed that early rehabilitation in the intensive care unit (ICU) reduces physical impairment and decreases ICU and hospital length of stay (LOS). However, these studies are based...

Cite
Wahab R, Yip NH, Chandra S, et al. The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study. J Intensive Care Soc. 2015;17(1):2-11doi: 10.1177/1751143715605118.
Wahab, R., Yip, N. H., Chandra, S., Nguyen, M., Pavlovich, K. H., Benson, T., Vilotijevic, D., Rodier, D. M., Patel, K. R., Rychcik, P., Perez-Mir, E., Boyle, S. M., Berlin, D., Needham, D. M., & Brodie, D. (2016). The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study. Journal of the Intensive Care Society, 17(1), 2-11. https://doi.org/10.1177/1751143715605118
Wahab, Romina, et al. "The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study." Journal of the Intensive Care Society vol. 17,1 (2016): 2-11. doi: https://doi.org/10.1177/1751143715605118
Wahab R, Yip NH, Chandra S, Nguyen M, Pavlovich KH, Benson T, Vilotijevic D, Rodier DM, Patel KR, Rychcik P, Perez-Mir E, Boyle SM, Berlin D, Needham DM, Brodie D. The implementation of an early rehabilitation program is associated with reduced length of stay: A multi-ICU study. J Intensive Care Soc. 2016 Feb;17(1):2-11. doi: 10.1177/1751143715605118. Epub 2015 Sep 21. PMID: 28979452; PMCID: PMC5606382.
Copy Download .nbib Format: NLM
The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1.

Pharmacology research & perspectives

Saaby L, Tfelt-Hansen P, Brodin B.
PMID: 26171231
Pharmacol Res Perspect. 2015 Aug;3(4):e00151. doi: 10.1002/prp2.151. Epub 2015 Jun 11.

Verapamil is used in high doses for the treatment of cluster headache. Verapamil has been described as a P-glycoprotein (P-gp, ABCB1) substrate. We wished to evaluate in vitro whether co administration of a P-gp inhibitor with verapamil could be...

Cite
Saaby L, Tfelt-Hansen P, Brodin B. The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1. Pharmacol Res Perspect. 2015;3(4):e00151doi: 10.1002/prp2.151.
Saaby, L., Tfelt-Hansen, P., & Brodin, B. (2015). The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1. Pharmacology research & perspectives, 3(4), e00151. https://doi.org/10.1002/prp2.151
Saaby, Lasse, et al. "The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1." Pharmacology research & perspectives vol. 3,4 (2015): e00151. doi: https://doi.org/10.1002/prp2.151
Saaby L, Tfelt-Hansen P, Brodin B. The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1. Pharmacol Res Perspect. 2015 Aug;3(4):e00151. doi: 10.1002/prp2.151. Epub 2015 Jun 11. PMID: 26171231; PMCID: PMC4492727.
Copy Download .nbib Format: NLM
Remote monitoring in heart failure.

European heart journal. Quality of care & clinical outcomes

Frenneaux MP, Gollop ND, Loudon BL, Parasuraman S.
PMID: 29474598
Eur Heart J Qual Care Clin Outcomes. 2015 Nov 01;1(2):45-46. doi: 10.1093/ehjqcco/qcv018.

No abstract available.

Cite
Frenneaux MP, Gollop ND, Loudon BL, et al. Remote monitoring in heart failure. Eur Heart J Qual Care Clin Outcomes. 2015;1(2):45-46doi: 10.1093/ehjqcco/qcv018.
Frenneaux, M. P., Gollop, N. D., Loudon, B. L., & Parasuraman, S. (2015). Remote monitoring in heart failure. European heart journal. Quality of care & clinical outcomes, 1(2), 45-46. https://doi.org/10.1093/ehjqcco/qcv018
Frenneaux, Michael P, et al. "Remote monitoring in heart failure." European heart journal. Quality of care & clinical outcomes vol. 1,2 (2015): 45-46. doi: https://doi.org/10.1093/ehjqcco/qcv018
Frenneaux MP, Gollop ND, Loudon BL, Parasuraman S. Remote monitoring in heart failure. Eur Heart J Qual Care Clin Outcomes. 2015 Nov 01;1(2):45-46. doi: 10.1093/ehjqcco/qcv018. PMID: 29474598.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Misrai V, Kerever S, Bordier B, Bruyère F, Karsenty G, Guillotreau J.
PMID: 26544221
Prog Urol. 2015 Nov;25(13):728. doi: 10.1016/j.purol.2015.08.026.

No abstract available.

Cite
Misrai V, Kerever S, Bordier B, et al. Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Prog Urol. 2015;25(13):728doi: 10.1016/j.purol.2015.08.026.
Misrai, V., Kerever, S., Bordier, B., Bruyère, F., Karsenty, G., & Guillotreau, J. (2015). Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 728. https://doi.org/10.1016/j.purol.2015.08.026
Misrai, V, et al. "Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 728. doi: https://doi.org/10.1016/j.purol.2015.08.026
Misrai V, Kerever S, Bordier B, Bruyère F, Karsenty G, Guillotreau J. Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes. [Not Available]. Prog Urol. 2015 Nov;25(13):728. doi: 10.1016/j.purol.2015.08.026. French. PMID: 26544221.
Copy Download .nbib Format: NLM
Lanthanoid/Alkali Metal β-Triketonate Assemblies: A Robust Platform for Efficient NIR Emitters.

Chemistry (Weinheim an der Bergstrasse, Germany)

Reid BL, Stagni S, Malicka JM, Cocchi M, Sobolev AN, Skelton BW, Moore EG, Hanan GS, Ogden MI, Massi M.
PMID: 26511032
Chemistry. 2015 Dec 07;21(50):18354-63. doi: 10.1002/chem.201502536. Epub 2015 Oct 29.

The reaction of hydrated lanthanoid chlorides with tribenzoylmethane and an alkali metal hydroxide consistently resulted in the crystallization of neutral tetranuclear assemblies with the general formula [Ln(Ae⋅HOEt)(L)4 ]2 (Ln=Eu(3+) , Er(3+) , Yb(3+) ; Ae=Na(+) , K(+) , Rb(+)...

Cite
Reid BL, Stagni S, Malicka JM, et al. Lanthanoid/Alkali Metal β-Triketonate Assemblies: A Robust Platform for Efficient NIR Emitters. Chemistry. 2015;21(50):18354-63doi: 10.1002/chem.201502536.
Reid, B. L., Stagni, S., Malicka, J. M., Cocchi, M., Sobolev, A. N., Skelton, B. W., Moore, E. G., Hanan, G. S., Ogden, M. I., & Massi, M. (2015). Lanthanoid/Alkali Metal β-Triketonate Assemblies: A Robust Platform for Efficient NIR Emitters. Chemistry (Weinheim an der Bergstrasse, Germany), 21(50), 18354-63. https://doi.org/10.1002/chem.201502536
Reid, Brodie L, et al. "Lanthanoid/Alkali Metal β-Triketonate Assemblies: A Robust Platform for Efficient NIR Emitters." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,50 (2015): 18354-63. doi: https://doi.org/10.1002/chem.201502536
Reid BL, Stagni S, Malicka JM, Cocchi M, Sobolev AN, Skelton BW, Moore EG, Hanan GS, Ogden MI, Massi M. Lanthanoid/Alkali Metal β-Triketonate Assemblies: A Robust Platform for Efficient NIR Emitters. Chemistry. 2015 Dec 07;21(50):18354-63. doi: 10.1002/chem.201502536. Epub 2015 Oct 29. PMID: 26511032.
Copy Download .nbib Format: NLM
Remacemide versus carbamazepine in newly diagnosed epilepsy.

Epilepsy & behavior : E&B

Whitehead J, Stevens J, Brodie M, Wroe S, Dean A, Holdich T.
PMID: 12609343
Epilepsy Behav. 2002 Aug;3(4):405-406. doi: 10.1016/s1525-5050(02)00044-6.

No abstract available.

Cite
Whitehead J, Stevens J, Brodie M, et al. Remacemide versus carbamazepine in newly diagnosed epilepsy. Epilepsy Behav. 2002;3(4):405-406doi: 10.1016/s1525-5050(02)00044-6.
Whitehead, J., Stevens, J., Brodie, M., Wroe, S., Dean, A., & Holdich, T. (2002). Remacemide versus carbamazepine in newly diagnosed epilepsy. Epilepsy & behavior : E&B, 3(4), 405-406. https://doi.org/10.1016/s1525-5050(02)00044-6
Whitehead, John, et al. "Remacemide versus carbamazepine in newly diagnosed epilepsy." Epilepsy & behavior : E&B vol. 3,4 (2002): 405-406. doi: https://doi.org/10.1016/s1525-5050(02)00044-6
Whitehead J, Stevens J, Brodie M, Wroe S, Dean A, Holdich T. Remacemide versus carbamazepine in newly diagnosed epilepsy. Epilepsy Behav. 2002 Aug;3(4):405-406. doi: 10.1016/s1525-5050(02)00044-6. PMID: 12609343.
Copy Download .nbib Format: NLM
Recruitment in health careers. Third national council on health careers.

Journal of the American Medical Women's Association

NEMIR R, BRODIE J.
PMID: 13938100
J Am Med Womens Assoc. 1963 Jan;18:47-8.

No abstract available.

Cite
NEMIR R, BRODIE J. Recruitment in health careers. Third national council on health careers. J Am Med Womens Assoc. 1963;18:47-8
NEMIR, R., & BRODIE, J. (1963). Recruitment in health careers. Third national council on health careers. Journal of the American Medical Women's Association, 1847-8.
NEMIR, R, and BRODIE, J. "Recruitment in health careers. Third national council on health careers." Journal of the American Medical Women's Association vol. 18 (1963): 47-8.
NEMIR R, BRODIE J. Recruitment in health careers. Third national council on health careers. J Am Med Womens Assoc. 1963 Jan;18:47-8. PMID: 13938100.
Copy Download .nbib Format: NLM
Letters to the Editor.

Science (New York, N.Y.)

Commoner B, Brode RB, Byerly TC, Coale AJ, Edsall JT, Frank LK, Mead M, Roberts WO, Wolfle D.
PMID: 17743918
Science. 1964 Feb 28;143(3609):915. doi: 10.1126/science.143.3609.915.

No abstract available.

Cite
Commoner B, Brode RB, Byerly TC, et al. Letters to the Editor. Science. 1964;143(3609):915doi: 10.1126/science.143.3609.915.
Commoner, B., Brode, R. B., Byerly, T. C., Coale, A. J., Edsall, J. T., Frank, L. K., Mead, M., Roberts, W. O., & Wolfle, D. (1964). Letters to the Editor. Science (New York, N.Y.), 143(3609), 915. https://doi.org/10.1126/science.143.3609.915
Commoner, B, et al. "Letters to the Editor." Science (New York, N.Y.) vol. 143,3609 (1964): 915. doi: https://doi.org/10.1126/science.143.3609.915
Commoner B, Brode RB, Byerly TC, Coale AJ, Edsall JT, Frank LK, Mead M, Roberts WO, Wolfle D. Letters to the Editor. Science. 1964 Feb 28;143(3609):915. doi: 10.1126/science.143.3609.915. PMID: 17743918.
Copy Download .nbib Format: NLM
The diagnosis of tuberculosis.

Clinics in chest medicine

Brodie D, Schluger NW.
PMID: 15837109
Clin Chest Med. 2005 Jun;26(2):247-71, vi. doi: 10.1016/j.ccm.2005.02.012.

Diagnostic testing for tuberculosis has remained unchanged for nearly a century, but newer technologies hold the promise of a true revolution in tuberculosis diagnostics. New tests may well supplant the tuberculin skin test in diagnosing latent tuberculosis infection in...

Cite
Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005;26(2):247-71, vidoi: 10.1016/j.ccm.2005.02.012.
Brodie, D., & Schluger, N. W. (2005). The diagnosis of tuberculosis. Clinics in chest medicine, 26(2), 247-71, vi. https://doi.org/10.1016/j.ccm.2005.02.012
Brodie, Daniel, and Schluger, Neil W. "The diagnosis of tuberculosis." Clinics in chest medicine vol. 26,2 (2005): 247-71, vi. doi: https://doi.org/10.1016/j.ccm.2005.02.012
Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005 Jun;26(2):247-71, vi. doi: 10.1016/j.ccm.2005.02.012. PMID: 15837109.
Copy Download .nbib Format: NLM
ACTIVE IMMUNIZATION IN MONKEYS AGAINST POLIOMYELITIS WITH GERMICIDALLY INACTIVATED VIRUS.

Science (New York, N.Y.)

Brodie M.
PMID: 17816263
Science. 1934 Jun 29;79(2061):594-5. doi: 10.1126/science.79.2061.594.

No abstract available.

Cite
Brodie M. ACTIVE IMMUNIZATION IN MONKEYS AGAINST POLIOMYELITIS WITH GERMICIDALLY INACTIVATED VIRUS. Science. 1934;79(2061):594-5doi: 10.1126/science.79.2061.594.
Brodie, M. (1934). ACTIVE IMMUNIZATION IN MONKEYS AGAINST POLIOMYELITIS WITH GERMICIDALLY INACTIVATED VIRUS. Science (New York, N.Y.), 79(2061), 594-5. https://doi.org/10.1126/science.79.2061.594
Brodie, M. "ACTIVE IMMUNIZATION IN MONKEYS AGAINST POLIOMYELITIS WITH GERMICIDALLY INACTIVATED VIRUS." Science (New York, N.Y.) vol. 79,2061 (1934): 594-5. doi: https://doi.org/10.1126/science.79.2061.594
Brodie M. ACTIVE IMMUNIZATION IN MONKEYS AGAINST POLIOMYELITIS WITH GERMICIDALLY INACTIVATED VIRUS. Science. 1934 Jun 29;79(2061):594-5. doi: 10.1126/science.79.2061.594. PMID: 17816263.
Copy Download .nbib Format: NLM
Active Immunization Against Poliomyelitis.

American journal of public health and the nation's health

Brodie M.
PMID: 18014136
Am J Public Health Nations Health. 1935 Jan;25(1):54-67. doi: 10.2105/ajph.25.1.54.

No abstract available.

Cite
Brodie M. Active Immunization Against Poliomyelitis. Am J Public Health Nations Health. 1935;25(1):54-67doi: 10.2105/ajph.25.1.54.
Brodie, M. (1935). Active Immunization Against Poliomyelitis. American journal of public health and the nation's health, 25(1), 54-67. https://doi.org/10.2105/ajph.25.1.54
Brodie, M. "Active Immunization Against Poliomyelitis." American journal of public health and the nation's health vol. 25,1 (1935): 54-67. doi: https://doi.org/10.2105/ajph.25.1.54
Brodie M. Active Immunization Against Poliomyelitis. Am J Public Health Nations Health. 1935 Jan;25(1):54-67. doi: 10.2105/ajph.25.1.54. PMID: 18014136; PMCID: PMC1558931.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 378 entries